Geneos Wealth Management Inc. View Ray, Inc. Transaction History

Geneos Wealth Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	$3.65 - $4.82 $29,951 - $39,552	-8,206 Reduced 49.97%	8,215 $36,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $3.97 $48,699 - $72,682	-18,308 Reduced 52.72%	16,421 $59,000
Q2 2022 Jul 22, 2022	BUY	$2.42 - $4.05 $13,363 - $22,364	5,522 Added 18.91%	34,729 $92,000
Q1 2022 May 16, 2022	BUY	$3.45 - $5.83 $54,592 - $92,253	15,824 Added 118.24%	29,207 $114,000
Q4 2021 Feb 09, 2022	SELL	$4.89 - $7.59 $10,044 - $15,589	-2,054 Reduced 13.31%	13,383 $73,000
Q3 2021 Nov 09, 2021	SELL	$5.18 - $7.41 $39,917 - $57,101	-7,706 Reduced 33.3%	15,437 $107,000
Q4 2020 May 19, 2021	BUY	$2.78 - $4.5 $64,337 - $104,143	23,143 New	23,143 $106,000

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.